Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lymphoma, Mantle-Cell × ixazomib × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 48 Lymphoma 5 Recurrence 3 Waldenstrom Macroglobulinemia 2 Leukemia, Plasma Cell 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2 Amyloidosis 2 Smoldering Multiple Myeloma 1 Plasmacytoma 1 Neoplasms, Plasma Cell 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Immunoglobulin Light-chain Amyloidosis 1 Hematologic Diseases 1 Glioblastoma 1 Chromosome 17 deletion 1 Alzheimer Disease 1 Advanced Non-hematologic Malignancies 1 Advanced Cancers 1

Interventions

Rituximab 117 Cyclophosphamide 112 Peripheral Blood Stem Cell Transplantation 60 fludarabine phosphate 58 Filgrastim 55 Etoposide 49 Vincristine 41 Whole-Body Irradiation 38 Cytarabine 38 Bortezomib 38 Mycophenolic Acid 36 Cyclosporine 36 Doxorubicin 35 Radiotherapy 33 Melphalan 32 ibrutinib 30 Prednisone 29 Methotrexate 28 Lenalidomide 26 Dexamethasone 26 Busulfan 26 Bendamustine Hydrochloride 26 Tacrolimus 24 Carmustine 22 Antilymphocyte Serum 21 Granulocyte Colony-Stimulating Factor 20 ibritumomab tiuxetan 17 fludarabine 16 sargramostim 14 Sirolimus 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03323151 2024-01-18

PrE0404

PrECOG, LLC.

Phase 1/2 Completed

43 enrolled 21 charts

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡